(Treatment of Psoriasis / pH Modification)
Muby Chem operates a state-of-the-art manufacturing facility producing Encapsulated Fumaric Acid, known for its exceptional purity and efficacy. This compound is particularly valuable in the pharmaceutical and skincare industry.
Our advanced encapsulation technology ensures superior stability and targeted release of Encapsulated Fumaric Acid, used as a component or precursor to fumarate esters, which are derivatives of fumaric acid, are used to treat psoriasis, a skin condition.
Application: MOLCOAT™ FUM is designed to allow the controlled release of Fumaric Acid, thereby preventing its rapid degradation in the stomach and enhancing its absorption in the gastrointestinal tract. This controlled release profile improves bioavailability and minimizes common side effects such as gastric irritation. Encapsulation technology makes it especially beneficial in the formulation of fumaric acid esters, such as dimethyl fumarate, which are widely used in the treatment of psoriasis due to their immunomodulatory and anti-inflammatory properties.
| # | TEST | SPECIFICATION |
|---|---|---|
| 1 | Appearance | It occurs as white to off white free flowing granules. |
| 2 | Hydrogenated soybean oil | 8.0% to 12.0% |
| 3 | Assay (Fumaric acid) | Not less than 88.0% and not more than 92.0% |
MOLCOAT™ FUM is packed in HDPE bag or HDPE drum with double PE liners inside and is provided with a barcoded label and a tamper-evident seal.
The shelf life is 3 years. It is preserved in well-closed containers.
This document and any information provided herein does not constitute a legally binding obligation of Muby Chem and has been prepared in good faith and is believed to be accurate as of the date of issuance. Unless expressly agreed otherwise in writing in a supply contract or other written agreement between you and Muby Chem: